Hair Restoration Clinics Compared: The Non-Delegable Acts Test

Hair Restoration Clinics Compared: The Non-Delegable Acts Test

Introduction: Why “Is This Clinic Good?” Is the Wrong Question

Hair loss is one of the most common conditions in medicine. Up to 80% of men and 50% of women will experience pattern hair loss (androgenetic alopecia) at some point in their lives. In the United States alone, an estimated 50 million men and 30 million women are affected. Most people who compare hair restoration clinics have already decided to treat their hair loss. Their remaining question is where to go.

That question is harder to answer than it looks. Boutique practices, hospital chains, franchise “hair mills,” and med-spa outfits all use nearly the same language: “board certified,” “expert surgeon,” “natural results.” When every clinic makes the same claims, choosing between them becomes a matter of gut feeling.

This article offers a different approach. It organizes the clinic landscape around one clinical criterion that patients can verify by asking about it in a consultation: the non-delegable acts standard set out by the American Board of Hair Restoration Surgery (ABHRS) and reflected in the ethical standards of the International Society of Hair Restoration Surgery (ISHRS).

The stakes are real. According to the ISHRS 2025 Practice Census, 59% of surgeons now report black-market clinics operating in their cities. Published comparisons also show a graft survival gap of 10 to 25 percentage points between doctor-performed and technician-performed procedures. The goal of this article is to give readers a test they can apply to any clinic type. It is neither a directory nor a generic checklist.

The Non-Delegable Acts Test, Defined

The American Board of Hair Restoration Surgery has established explicit guidelines on which procedural steps cannot be delegated to non-physicians. Two acts fall into this category:

  1. Creating extraction incisions, which is the harvesting of grafts from the donor area.
  2. Creating recipient site incisions, which are the placement sites that determine the density, angle, and direction of the transplanted hair.

These two steps are singled out because they are the technical core of the procedure. Extraction technique governs transection rates, meaning how many follicles are damaged during harvesting. Recipient site creation shapes the hairline, the direction of growth, and whether the result looks natural. Together, these steps largely determine graft survival and the final appearance. Other tasks in the procedure are important, but they are peripheral to these two.

Who Can Legally Perform What

Hair restoration surgery is a team effort, and trained technicians play a legitimate role. In many jurisdictions, technicians may handle:

  • Graft placement or implantation into sites the physician has already created
  • Graft sorting, trimming, and preservation under magnification
  • Patient preparation and support throughout the day

The two non-delegable acts are different. Under ABHRS/ISHRS ethical standards, the physician of record must personally create both the extraction incisions and the placement incisions. Supervising from the doorway does not meet this standard, and neither does being somewhere in the building.

The physician of record is the surgeon whose license and name are on the case. That surgeon is accountable for these steps no matter who else is in the room. When a clinic names a surgeon, the patient is entitled to know whether that surgeon is the one holding the instrument during extraction and site creation.

A Note on Credentialing Language

Patients should also understand what credentials actually mean. ABHRS is a self-designated board that does not require an ACGME-accredited residency, so it does not meet American Board of Medical Specialties (ABMS) standards for physician competency. For that reason, ABHRS members must advertise themselves as “Diplomates,” not as “board certified” hair restoration surgeons.

This distinction is worth listening for in a consultation. A physician may be board certified by an ABMS member board in a specialty such as dermatology or surgery and also hold ABHRS Diplomate status. These are two separate credentials, and clear communication keeps them separate. Understanding what makes a great hair transplant surgeon starts with untangling this kind of credentialing language.

The ABHRS designation is also uncommon. Only about 200 hair surgeons worldwide hold Diplomate status, while the number of clinics offering hair transplants is far larger. Rigorous credentialing is the exception in this field.

Why This Test Matters Now: The Data Behind the Standard

The clearest evidence for the non-delegable acts standard is the difference in outcomes. Doctor-performed procedures consistently report graft survival rates of 90 to 97%, compared with 70 to 85% for technician-performed procedures. That 10 to 25 point gap directly affects how dense and natural the final result looks. Grafts that do not survive do not grow, and donor hair used on a failed graft cannot be recovered.

The trend is getting worse:

The non-delegable acts test is designed to catch a practice that specialists call the “ghost clinic” or “bait-and-switch.” In this arrangement, a credentialed surgeon lends their name and license to a clinic but is not present for the critical surgical steps. The patient books with a name they researched, and a technician they never met does the actual work.

The legal picture adds another layer of risk. A peer-reviewed review of North American hair transplant litigation found that medical malpractice and lack of informed consent were the most common legal claims. Technicians are typically not covered by malpractice insurance. A patient harmed by a technician-performed procedure may therefore have no meaningful legal protection.

The size of the industry helps explain why delegation practices vary so much. Turkey alone performed over 1.5 million procedures in 2024, accounting for more than 60% of global hair transplant medical tourism. FUE now makes up roughly 65% of global procedure volume. At that scale, practices range from rigorous surgeon-led care to assembly-line production. Patients need a consistent way to tell them apart.

Mapping the Four Clinic Models Against the Non-Delegable Acts Test

Patients comparing options usually encounter four main clinic models. Each can be measured against the same question: who performs extraction and recipient site creation?

Boutique Surgeon-Led Practices

The model: A small, physician-owned practice where the named surgeon personally performs extraction and recipient site work. The surgeon is usually supported by a small, consistent surgical team.

How it relates to the test: The surgery schedule itself indicates whether the practice can comply. A strict one-patient-per-day policy works as an operational proxy for non-delegable acts compliance. One physician cannot personally extract grafts and create sites for several surgeries happening at once. A practice that limits itself to one surgical patient per day is organized so the physician can actually do both non-delegable steps.

The trade-off: This model usually means longer waits for a surgery date, because capacity is limited on purpose. In exchange, patients have much greater assurance that the non-delegable steps stay with the physician of record.

An illustrative example: Shapiro Medical Group in Minneapolis, Minnesota, fits this model. The practice has focused exclusively on hair transplantation since 1990. Its physicians include Dr. Ron Shapiro, co-author of a leading hair transplant reference textbook that many physicians call the “Hair Transplant Bible.” The medical team has lectured at more than 100 conferences in over 20 countries. Physicians from other practices come to the clinic both to learn techniques and to have their own procedures done. The practice’s one-patient-per-day model is built around individualized surgical attention, not volume.

Hospital-Based International Chains

The model: Procedures take place inside larger hospital or medical-tourism facilities. These organizations often employ multiple surgeons and use standardized protocols across locations.

The verification challenge: Facility credentials and surgeon credentials are separate questions. Hospital licensing or JCI accreditation shows that a facility meets institutional standards. It does not show which person performs extraction and recipient site creation on a particular patient’s case. Patients need to ask about the surgeon separately from the facility.

The regulatory backdrop: This model is especially common in Turkey, where over 1.5 million procedures were performed in 2024. Oversight varies widely even within one country. Patient-safety analyses of the Turkish market in 2026 estimate that 15 to 20% of clinics operating in Istanbul lack proper Ministry of Health licensing. A well-known institutional name does not replace direct questions about the individual case.

High-Volume Franchise “Hair Mills”

The model: Each surgeon has several surgeries scheduled per day. Technicians perform most or all of the hands-on surgical steps, and a supervising physician may move between operating rooms.

How it relates to the test: This structure creates the bait-and-switch risk that ISHRS commentary describes. The credentialed name in the marketing may not be the person who physically performs extraction and recipient site creation. When several procedures run at the same time, it is physically impossible for one surgeon to personally perform the non-delegable acts on all of them.

Connection to outcomes: This is the setting where the 70 to 85% graft survival range for technician-performed work, and the rising number of repair cases, are most concentrated. The problem stems from the structure of the model itself, which makes it predictable.

Med-Spa and Technician-Run Outfits

The model: Hair restoration is offered as a side service within a broader aesthetics or wellness business. These operations are often staffed mainly by technicians, with limited or off-site physician involvement.

The malpractice gap: Because technicians are typically not covered by malpractice insurance, patients treated in these settings may have little or no legal recourse if extraction or recipient site work goes wrong. The informed consent process may also fail to state clearly who is performing which part of the surgery.

Where it sits: This model is the furthest from ABHRS/ISHRS non-delegable acts compliance. Patients considering it should ask the most direct and specific questions before booking.

How to Apply the Test During a Consultation

A consultation should be treated as a verification session, not a sales meeting. The patient has a specific question and is entitled to a specific answer. Everything else discussed can be weighed against that answer.

The Questions to Ask Directly

  1. “Who will personally perform my extraction and recipient site creation: you, the physician of record, or a technician?” This is the central question. A compliant practice can answer it plainly.
  2. “How many procedures are scheduled on the same day as mine?” If several surgeries are scheduled at once, the physician cannot personally perform the non-delegable acts on all of them.
  3. “What credentials does the physician hold, and how are they described?” Listen for “Diplomate of the American Board of Hair Restoration Surgery,” and check whether any “board certified” claim refers to a recognized ABMS board in a named specialty. Vague or blended credential language is a concern.
  4. “May I see outcome photos taken at twelve months or later?” Transplanted hairs normally shed within two to eight weeks and begin regrowing around month three. Photos taken earlier than twelve months cannot show whether the grafts actually survived.

Red Flags That Signal a Failed Test

  • Vague or deflected answers about who performs extraction and site creation, such as “our team is highly trained,” with no statement of who does what.
  • Refusal or inability to confirm the operating surgeon’s name before the procedure date.
  • Marketing that emphasizes graft counts or speed and says nothing about physician involvement in the core surgical steps.
  • No malpractice coverage disclosure, and no informed consent documents that specify who performs each portion of the surgery.

A single red flag does not always mean a clinic should be ruled out. It does mean the patient should keep asking until the answer is clear.

Beyond the Test: Complementary Due Diligence

The non-delegable acts test works best as the first filter. Once a clinic passes it, other checks help complete the picture.

Realistic graft planning. First-time procedures in 2024 averaged 2,347 grafts, up from 2,176 in 2021, and repeat procedures averaged 1,637 grafts. A single first procedure can use nearly 40% of a patient’s lifetime donor supply. This matters especially for younger patients: 95% of first-time surgical patients in 2024 began treatment between ages 20 and 35, so hair loss will likely continue for decades after surgery. A credible consultation should include a discussion of how to conserve the donor supply over time.

Experience with changing patient groups. The number of female surgical patients rose 16.5% from 2021 to 2024. Female hair loss often requires different techniques; for example, FUT is frequently the better approach for women. Another new group includes users of GLP-1 weight loss medications such as Ozempic and Wegovy, some of whom experience hair shedding. A clinic’s familiarity with these patients says something about its clinical depth.

Medical and non-surgical options. In dermatology, the standard treatment remains minoxidil and finasteride, with transplantation as one surgical option. The American Academy of Dermatology and similar organizations stress diagnosing the cause of hair loss before choosing a treatment. Reputable practices discuss medical therapy, regenerative options, and non-surgical approaches such as scalp micropigmentation as part of a full evaluation, and they do not simply steer every patient toward surgery.

Aftercare and documentation. After the non-delegable acts question has been answered satisfactorily, patients should review the clinic’s aftercare plan, its follow-up schedule for patients traveling from out of town, and the informed consent documents.

Conclusion: Turning a Trust Question Into a Clinical Answer

Hair restoration clinics range from boutique surgeon-led practices to high-volume hair mills and technician-run outfits. Marketing language makes them sound alike. One question reliably separates them: who performs the non-delegable acts?

The evidence connects this question to outcomes. A 10 to 25 point gap in graft survival, black-market clinics reported by 59% of surgeons, and a rising share of repair cases all trace back to whether the physician or a technician performs extraction and recipient site creation.

The test turns an emotional trust judgment into a factual question that any patient can ask in any consultation, whatever the clinic type or location. Practices that build physician-performed non-delegable acts into their structure, for example through strict daily volume limits, find this question easy to answer.

Ready to Ask the Right Questions?

Patients can bring the non-delegable acts test to their next consultation, whichever clinic they are evaluating. The central question is simple: who will personally perform extraction and recipient site creation?

Patients who want a surgeon-led, individualized approach can schedule a consultation with Shapiro Medical Group in Minneapolis. Its physicians personally lead surgical care under a one-patient-per-day model, and the practice welcomes patients from Minnesota, other states, and abroad. During that consultation, patients can ask who performs extraction and recipient site creation and compare the answer against the standards described in this article.

Facebook
Twitter
LinkedIn
Other Post You may like
Conceptual illustration of regenerative cell therapy for hair growth with glowing cellular elements

Regenerative Cell Therapy for Hair Growth: The 2026 Evidence Map

This 2026 evidence map breaks down regenerative cell therapy for hair growth, ranking PRP, conditioned medium, exosomes, and stem cell/SVF treatments by clinical trial strength and regulatory status. Learn how these options compare to FDA-approved therapies and where they fit into a realistic, non-surgical hair restoration plan.

Read More
Doctor consulting patient at a trusted hair restoration clinic

Hair Restoration Clinics Compared: The Non-Delegable Acts Test

Choosing between hair restoration clinics can feel like a coin flip when every practice claims to be ‘board certified’ and ‘expert.’ This article breaks down the non-delegable acts standard—a clinical test patients can use to separate doctor-led surgery from technician-run operations before they commit.

Read More